The Medicines and Healthcare products Regulatory Agency (MHRA) and the National Institute for Health and Care Excellence (NICE) have launched a call for evidence to evaluate the impact of resources developed under the Wellcome-funded Digital Mental Health Technologies (DMHT) programme. The survey opened on 5 November 2026 and will remain open until 26 February 2027.
According to the two organisations, the exercise forms part of the programme's Phase 1 evaluation. It aims to assess how the resources have been received and used across the sector, and in particular whether the materials have influenced users' knowledge, confidence, decision-making and professional practice.
The resources were developed to support the safe development, regulation, evaluation and adoption of digital mental health technologies, a category that includes mental health apps and other digital tools.
The agencies are seeking feedback from a broad range of stakeholders: developers and manufacturers of digital mental health technologies, healthcare professionals, researchers, policymakers, regulators, people with lived experience of mental health conditions, carers and members of the public. They said participation is encouraged whether respondents have engaged extensively, minimally or not at all with the existing materials.
Findings from the survey will help determine whether the Phase 1 outputs have achieved their intended objectives and will inform the future direction of Phase 2 of the DMHT programme. The MHRA and NICE said the feedback would help identify strengths, highlight areas for improvement and shape future work to improve the safety and effectiveness of digital mental health technologies.